Dopamine	0	8	B-Drug_or_compound
regulates	9	18	O
phosphorylation	19	34	O
of	35	37	O
VEGF	38	42	B-Gene_or_gene_product
receptor	43	51	I-Gene_or_gene_product
2	52	53	I-Gene_or_gene_product
by	54	56	O
engaging	57	65	O
Src	66	69	B-Gene_or_gene_product
-	69	70	I-Gene_or_gene_product
homology	70	78	I-Gene_or_gene_product
-	78	79	I-Gene_or_gene_product
2	79	80	I-Gene_or_gene_product
-	80	81	I-Gene_or_gene_product
domain	81	87	I-Gene_or_gene_product
-	87	88	I-Gene_or_gene_product
containing	88	98	I-Gene_or_gene_product
protein	99	106	I-Gene_or_gene_product
tyrosine	107	115	I-Gene_or_gene_product
phosphatase	116	127	I-Gene_or_gene_product
2	128	129	I-Gene_or_gene_product
.	129	130	O

Vascular	132	140	B-Gene_or_gene_product
endothelial	141	152	I-Gene_or_gene_product
growth	153	159	I-Gene_or_gene_product
factor	160	166	I-Gene_or_gene_product
(	167	168	O
VEGF	168	172	B-Gene_or_gene_product
)	172	173	O
-	173	174	O
induced	174	181	O
receptor	182	190	O
phosphorylation	191	206	O
is	207	209	O
the	210	213	O
crucial	214	221	O
step	222	226	O
for	227	230	O
initiating	231	241	O
downstream	242	252	O
signaling	253	262	O
pathways	263	271	O
that	272	276	O
lead	277	281	O
to	282	284	O
angiogenesis	285	297	O
or	298	300	O
related	301	308	O
pathophysiological	309	327	O
outcomes	328	336	O
.	336	337	O

Our	338	341	O
previous	342	350	O
studies	351	358	O
have	359	363	O
shown	364	369	O
that	370	374	O
the	375	378	O
neurotransmitter	379	395	O
dopamine	396	404	B-Drug_or_compound
could	405	410	O
inhibit	411	418	O
VEGF	419	423	B-Gene_or_gene_product
-	423	424	O
induced	424	431	O
phosphorylation	432	447	O
of	448	450	O
VEGF	451	455	B-Gene_or_gene_product
receptor	456	464	I-Gene_or_gene_product
2	465	466	I-Gene_or_gene_product
(	467	468	O
VEGFR	468	473	B-Gene_or_gene_product
-	473	474	I-Gene_or_gene_product
2	474	475	I-Gene_or_gene_product
)	475	476	O
,	476	477	O
endothelial	478	489	B-Cell
cell	490	494	I-Cell
proliferation	495	508	O
,	508	509	O
migration	510	519	O
,	519	520	O
microvascular	521	534	B-Tissue
permeability	535	547	O
,	547	548	O
and	549	552	O
thus	553	557	O
,	557	558	O
angiogenesis	559	571	O
.	571	572	O

In	573	575	O
this	576	580	O
study	581	586	O
,	586	587	O
we	588	590	O
address	591	598	O
the	599	602	O
mechanism	603	612	O
by	613	615	O
which	616	621	O
VEGFR	622	627	B-Gene_or_gene_product
-	627	628	I-Gene_or_gene_product
2	628	629	I-Gene_or_gene_product
phosphorylation	630	645	O
is	646	648	O
regulated	649	658	O
by	659	661	O
dopamine	662	670	B-Drug_or_compound
.	670	671	O

Here	672	676	O
,	676	677	O
we	678	680	O
demonstrate	681	692	O
that	693	697	O
D2	698	700	B-Gene_or_gene_product
dopamine	701	709	I-Gene_or_gene_product
receptor	710	718	I-Gene_or_gene_product
(	719	720	O
D2DR	720	724	B-Gene_or_gene_product
)	724	725	O
colocalizes	726	737	O
with	738	742	O
VEGFR	743	748	B-Gene_or_gene_product
-	748	749	I-Gene_or_gene_product
2	749	750	I-Gene_or_gene_product
at	751	753	O
the	754	757	O
cell	758	762	B-Cellular_component
surface	763	770	I-Cellular_component
.	770	771	O

Dopamine	772	780	B-Drug_or_compound
pretreatment	781	793	O
increases	794	803	O
the	804	807	O
translocation	808	821	O
and	822	825	O
colocalization	826	840	O
of	841	843	O
Src	844	847	B-Gene_or_gene_product
-	847	848	I-Gene_or_gene_product
homology	848	856	I-Gene_or_gene_product
-	856	857	I-Gene_or_gene_product
2	857	858	I-Gene_or_gene_product
-	858	859	I-Gene_or_gene_product
domain	859	865	I-Gene_or_gene_product
-	865	866	I-Gene_or_gene_product
containing	866	876	I-Gene_or_gene_product
protein	877	884	I-Gene_or_gene_product
tyrosine	885	893	I-Gene_or_gene_product
phosphatase	894	905	I-Gene_or_gene_product
(	906	907	O
SHP	907	910	B-Gene_or_gene_product
-	910	911	I-Gene_or_gene_product
2	911	912	I-Gene_or_gene_product
)	912	913	O
with	914	918	O
D2DR	919	923	B-Gene_or_gene_product
at	924	926	O
the	927	930	O
cell	931	935	B-Cellular_component
surface	936	943	I-Cellular_component
.	943	944	O

Dopamine	945	953	B-Drug_or_compound
administration	954	968	O
leads	969	974	O
to	975	977	O
increased	978	987	O
VEGF	988	992	B-Gene_or_gene_product
-	992	993	O
induced	993	1000	O
phosphorylation	1001	1016	O
of	1017	1019	O
SHP	1020	1023	B-Gene_or_gene_product
-	1023	1024	I-Gene_or_gene_product
2	1024	1025	I-Gene_or_gene_product
and	1026	1029	O
this	1030	1034	O
increased	1035	1044	O
phosphorylation	1045	1060	O
parallels	1061	1070	O
the	1071	1074	O
increased	1075	1084	O
phosphatase	1085	1096	O
activity	1097	1105	O
of	1106	1108	O
SHP	1109	1112	B-Gene_or_gene_product
-	1112	1113	I-Gene_or_gene_product
2	1113	1114	I-Gene_or_gene_product
.	1114	1115	O

Active	1116	1122	O
SHP	1123	1126	B-Gene_or_gene_product
-	1126	1127	I-Gene_or_gene_product
2	1127	1128	I-Gene_or_gene_product
then	1129	1133	O
dephosphorylates	1134	1150	O
VEGFR	1151	1156	B-Gene_or_gene_product
-	1156	1157	I-Gene_or_gene_product
2	1157	1158	I-Gene_or_gene_product
at	1159	1161	O
Y951	1162	1166	B-Protein_domain_or_region
,	1166	1167	O
Y996	1168	1172	B-Protein_domain_or_region
and	1173	1176	O
Y1059	1177	1182	B-Protein_domain_or_region
,	1182	1183	O
but	1184	1187	O
not	1188	1191	O
Y1175	1192	1197	B-Protein_domain_or_region
.	1197	1198	O

We	1199	1201	O
also	1202	1206	O
observe	1207	1214	O
that	1215	1219	O
SHP	1220	1223	B-Gene_or_gene_product
-	1223	1224	I-Gene_or_gene_product
2	1224	1225	I-Gene_or_gene_product
knockdown	1226	1235	O
impairs	1236	1243	O
the	1244	1247	O
dopamine	1248	1256	B-Drug_or_compound
-	1256	1257	O
regulated	1257	1266	O
inhibition	1267	1277	O
of	1278	1280	O
VEGF	1281	1285	B-Gene_or_gene_product
-	1285	1286	O
induced	1286	1293	O
phosphorylation	1294	1309	O
of	1310	1312	O
VEGFR	1313	1318	B-Gene_or_gene_product
-	1318	1319	I-Gene_or_gene_product
2	1319	1320	I-Gene_or_gene_product
and	1321	1324	O
,	1324	1325	O
subsequently	1326	1338	O
,	1338	1339	O
Src	1340	1343	B-Gene_or_gene_product
phosphorylation	1344	1359	O
and	1360	1363	O
migration	1364	1373	O
.	1373	1374	O

Our	1375	1378	O
data	1379	1383	O
establish	1384	1393	O
a	1394	1395	O
novel	1396	1401	O
role	1402	1406	O
for	1407	1410	O
SHP	1411	1414	B-Gene_or_gene_product
-	1414	1415	I-Gene_or_gene_product
2	1415	1416	I-Gene_or_gene_product
phosphatase	1417	1428	I-Gene_or_gene_product
in	1429	1431	O
the	1432	1435	O
dopamine	1436	1444	B-Drug_or_compound
-	1444	1445	O
mediated	1445	1453	O
regulation	1454	1464	O
of	1465	1467	O
VEGFR	1468	1473	B-Gene_or_gene_product
-	1473	1474	I-Gene_or_gene_product
2	1474	1475	I-Gene_or_gene_product
phosphorylation	1476	1491	O
.	1491	1492	O

